IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Citizens Business Bank

Citizens Business Bank lessened its position in IQVIA Holdings Inc. (NYSE:IQV) by 5.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 11,808 shares of the medical research company’s stock after selling 695 shares during the period. Citizens Business Bank’s holdings in IQVIA were worth $2,732,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in IQV. AdvisorNet Financial Inc lifted its holdings in shares of IQVIA by 327.6% in the 4th quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock valued at $29,000 after buying an additional 95 shares during the period. BKM Wealth Management LLC purchased a new position in IQVIA in the fourth quarter valued at about $32,000. Activest Wealth Management acquired a new stake in shares of IQVIA during the 4th quarter valued at approximately $35,000. CVA Family Office LLC purchased a new stake in shares of IQVIA during the 4th quarter worth approximately $43,000. Finally, CoreFirst Bank & Trust purchased a new position in IQVIA in the 3rd quarter valued at approximately $44,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on IQV. UBS Group boosted their target price on IQVIA from $240.00 to $300.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Barclays increased their target price on IQVIA from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Truist Financial boosted their price target on IQVIA from $286.00 to $297.00 and gave the stock a “buy” rating in a report on Tuesday, February 27th. Robert W. Baird increased their price objective on IQVIA from $226.00 to $251.00 and gave the company a “neutral” rating in a research note on Thursday, February 15th. Finally, StockNews.com raised shares of IQVIA from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, IQVIA currently has a consensus rating of “Moderate Buy” and a consensus target price of $256.80.

Insider Transactions at IQVIA

In other news, insider Kevin C. Knightly sold 8,607 shares of the business’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $250.17, for a total transaction of $2,153,213.19. Following the completion of the sale, the insider now owns 5,251 shares in the company, valued at approximately $1,313,642.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Kevin C. Knightly sold 8,607 shares of IQVIA stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $250.17, for a total transaction of $2,153,213.19. Following the transaction, the insider now owns 5,251 shares in the company, valued at approximately $1,313,642.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ari Bousbib sold 31,678 shares of the stock in a transaction on Friday, March 1st. The shares were sold at an average price of $250.53, for a total value of $7,936,289.34. Following the completion of the sale, the insider now owns 796,752 shares of the company’s stock, valued at $199,610,278.56. The disclosure for this sale can be found here. Insiders have sold a total of 41,285 shares of company stock worth $10,331,003 in the last three months. 1.60% of the stock is currently owned by company insiders.

IQVIA Trading Down 1.6 %

Shares of IQV traded down $3.68 during mid-day trading on Tuesday, hitting $231.80. The company had a trading volume of 674,185 shares, compared to its average volume of 963,709. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $261.73. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 2.12. The business’s 50-day simple moving average is $245.21 and its 200-day simple moving average is $223.56. The stock has a market cap of $42.07 billion, a PE ratio of 32.30, a P/E/G ratio of 2.27 and a beta of 1.50.

IQVIA (NYSE:IQV) last announced its quarterly earnings data on Wednesday, February 14th. The medical research company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.82 by $0.02. The company had revenue of $3.87 billion during the quarter, compared to analysts’ expectations of $3.80 billion. IQVIA had a net margin of 9.06% and a return on equity of 29.32%. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the company earned $2.54 EPS. Sell-side analysts forecast that IQVIA Holdings Inc. will post 10.12 earnings per share for the current year.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.